CD1D and neoplasm: Remarkably, even under conditions of high tumor burden and BCMA+CD1d− tumor cells, Allo/U15BCAR-NKT cells continued to effectively suppress tumor growth and achieved superior tumor clearance (Figures 5F and 5G).